Lehigh Valley Health admits to controlled substances violations in $2.75M settlement

A health system in Pennsylvania has agreed to a $2.75 million fine to resolve claims made by the U.S. Department of Justice (DOJ) that it failed to stop drug theft and diversion from its pharmacies, in violation of the Controlled Substances Act. 

Lehigh Valley Health Network agreed to the settlement, stemming from a series of incidents where a pharmacy technician illegally siphoned drugs from one of its hospitals, then forged paperwork to cover their tracks. 

The unnamed technician used passwords from another employee to hide their actions, though the DOJ did not say if the credentials were stolen or if that individual faces any charges. 

According to an announcement from prosecutors, Lehigh Valley admits guilt in failing to control the drugs, with security being inadequate to prevent theft. The health system was also accused of improper record keeping of stocks, which the DOJ said contributed to the diversions.

In statements sent to multiple media outlets, a spokesperson for Lehigh Valley said its hospitals are working with authorities to identify other violations of the Controlled Substances Act and secure its pharmacies from future theft. 

Additionally, the health system said its made enhancements to security that includes the adoption of a drug diversion detection application to better monitor clinician access to drugs. 

“We have worked diligently to strengthen controlled substance security and compliance to protect the well-being of the patients and communities we serve,” the spokesperson added.